Emily Gibbons, Gilead Sciences: the lenacapavir partnership

Take as Directed by CSIS Global Health Policy Center | Center for Strategic and International Studies

Gilead Sciences, the Trump administration, and the Global Fund have joined in partnership to bring lenacapavir, the new twice-yearly injectable prevention tool against HIV/AIDS, to two million persons at-risk in ten Afri...View more